Clinton; Gail M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Clinton; Gail M..The latest application filed is for "her-2 binding antagonists".

Company Profile

0.8.12

Clinton; Gail M. - Wimberley TX
Clinton; Gail M. - Portland OR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Her-2 Binding Antagonists App 20120088255 - Doherty; Joni K. ; et al.	2012-04-12
Her-2 Binding Antagonists App 20120045755 - Clinton; Gail M. ; et al.	2012-02-23
Method of treating cancer by inhibition of p95HER-2 production Grant 8,093,216 - Clinton January 10, 2	2012-01-10
HER-2 binding antagonists Grant 7,939,080 - Doherty , et al. May 10, 2	2011-05-10
HER-2 binding antagonists Grant 7,935,784 - Clinton , et al. May 3, 2	2011-05-03
Her-2 Binding Antagonists App 20100267027 - Clinton; Gail M. ; et al.	2010-10-21
Compositions And Methods For Treating Cancer By Modulating Her-2 And Egf Receptors App 20100119521 - CLINTON; GAIL M.	2010-05-13
HER-2 binding antagonists Grant 7,625,859 - Clinton , et al. December 1, 2	2009-12-01
Her-2 Binding Antagonists App 20090270316 - Doherty; Joni K. ; et al.	2009-10-29
Compositions and methods for treating cancer by modulating HER-2 and EGF receptors Grant 7,608,269 - Clinton October 27, 2	2009-10-27
Her-2 binding antagonists App 20080219997 - Clinton; Gail M. ; et al.	2008-09-11
Compositions and Methods for Treating Disease App 20080206231 - Clinton; Gail M. ; et al.	2008-08-28
Compositions and methods for treating cancer by modulating HER-2 and EGF receptors Grant 7,396,810 - Clinton July 8, 2	2008-07-08
HER-2 binding antagonists Grant 7,393,823 - Doherty , et al. July 1, 2	2008-07-01
Compositions and methods for modulating signaling mediated by IGF-1 receptor and erbB receptors App 20050272637 - Clinton, Gail M. ; et al.	2005-12-08
Intron fusion proteins, and methods of identifying and using same App 20050239088 - Shepard, H. Michael ; et al.	2005-10-27
Expression of herstatin, an alternative to her-2/neu product, in cells that express either p85her-2 or the egf receptor inhibits receptor activity and cell growth App 20040052796 - Clinton, Gail M.	2004-03-18
Expression of herstatin, an alternative HER-2/neu product, in cells that express either p185HER-2 or the EGF receptor inhibits receptor activity and cell growth App 20040022785 - Clinton, Gail M. ; et al.	2004-02-05
N-terminally truncated HER-2/neu protein as a cancer prognostic indicator App 20030059863 - Clinton, Gail M.	2003-03-27
HER-2 binding antagonists Grant 6,414,130 - Doherty , et al. July 2, 2	2002-07-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.